Sebastian Soluch Mba

Sebastian Soluch, PhD MBA, is an experienced professional in the field of market access and reimbursement strategy. Sebastian has held various leadership roles in reputable companies, demonstrating their expertise in this area.

Starting in 2023, Soluch joined Glaukos Corporation as the Senior Director of Market Access Strategy and Reimbursement. Prior to this, they worked at KOWA PHARMACEUTICAL EUROPE CO. LTD. as the Market Access Director from 2021 to 2022. Additionally, they served as a Strategic Advisor at Affibody AB during the same period.

From 2019 to 2021, Soluch held the position of Head of Market Access and Pricing, EMEA at Stemline Therapeutics, Inc. Before that, they worked as the Global Head of Market Access at Advanced Accelerator Applications from 2016 to 2019.

Soluch has also contributed their expertise to CSL Behring as the European Market Access Director from 2014 to 2016, and to Allergan as the Senior Health Economics, Pricing and Reimbursement, and Access Manager, EMEA in 2014. Prior to that, they served as the Head of Health Policy at Sanofi Pasteur from 2010 to 2013.

Beginning their career, Soluch worked at Novartis as a Market Access Manager from 2007 to 2009, and at Solvay as a Global Health Economist from 2005 to 2007.

Overall, Sebastian Soluch has accumulated a wealth of experience in market access and reimbursement strategy, holding various leadership roles in diverse organizations throughout their career.

Sebastian Soluch, PhD MBA, has an extensive education history in the field of Pharmacoeconomics and Pharmaceutical Sciences. Sebastian began their education at the Medical University of Lublin, where they obtained their Master's degree in Pharmaceutical Sciences from 1994 to 1999.

Following this, they pursued further education at the same institution and earned their Doctor of Philosophy (Ph.D.) in Pharmacoeconomics from 1999 to 2004. This allowed him to deepen their expertise in the economics of pharmaceuticals and its related field.

In addition to their studies in pharmacoeconomics, Sebastian Soluch also expanded their knowledge in general and strategic management by completing an MBA program at the Maastricht School of Management from 1999 to 2001. This provided him with a comprehensive understanding of management principles and their application in various industries.

To augment their academic qualifications, Sebastian Soluch obtained a B2 German Language Certification from the State Secretariat for Migration SEM in Switzerland in June 2021. This certification showcases their proficiency in the German language, which can be beneficial for international collaborations or employment opportunities.

Throughout their education journey, Sebastian Soluch has acquired a diverse range of expertise in pharmaceutical sciences, pharmacoeconomics, and general management with the completion of their Master's degree, Ph.D., MBA, and language certification.